MONDAY, OCTOBER 27TH

VIRTUAL SESSIONS ARE NOT LIVE STREAMED. THEY WILL BE RECORDED AND PUBLISHED LATER FOR VIEWING.

7:30am - 5:00pm

Registration Open

8:00am - 9:45am

PLENARY SESSION 4 - Understanding and Optimizing the Immunotherapy Response (I)

8:00am - 8:20am

PD1 and Memory a Smoking Gun in Melanoma Immunotherapy and Toxicity

Niroshana Anandasabapathy

8:20am - 8:35am

Selected Abstract Talk

TBD

8:35pm - 8:55pm

Clinical translation of new approaches in TIL therapy for metastatic melanoma

Michelle Krogsgaard

8:55pm - 9:10am

Selected Abstract Talk

TBD

9:10am - 9:30am

Improving mRNA Vaccines in Melanoma

Inge Svane

9:30am - 9:45am

Selected Abstract Talk

TBD

9:45am - 9:50am

Poster Flash Talks

9:50am - 10:10am

Refreshment Break

10:10am - 11:55am

PLENARY SESSION 5 - Melanoma Microenvironment

10:10am - 10:30am

Cancer’s Cradle: How Malignant Cells and Their Niche Trigger Tumor Initiation

Lukas Sommer

10:30am - 10:45am

Selected Abstract Talk

TBD

10:45am - 11:05am

A Complex TIME: How the Aging Tumor Immune Microenvironment Impacts Tumor Progression and Response to Therapy

Ashi Weeraratna

11:05am - 11:20am

Selected Abstract Talk

TBD

11:20am - 11:40am

Melanoma Control by the Gut Microbiome

Ze'ev Ronai

11:40am - 11:55am

Selected Abstract Talk

TBD

11:55am - 12:00pm

Poster Flash Talks

12:00pm - 1:30pm

Lunch - Exhibit & Posters

1:30pm - 3:15pm

PLENARY SESSION 6 - Rare and Challenging Melanomas

1:30pm - 1:50pm

Defining Therapeutic Targets in Rare Melanomas Using Genome-Wide and Combinatorial CRISPR Screening

David Adams

1:50pm - 2:05pm

Selected Abstract Talk

TBD

2:05pm - 2:25pm

TERT Activation in Acral and Mucosal Melanoma

James Wilmott

2:25pm - 2:40pm

Selected Abstract Talk

TBD

2:40pm - 3:00pm

Spatial Transcriptome of Immunotherapy Resistant Melanoma.

Boris Bastian

3:00pm - 3:15pm

Selected Abstract Talk

TBD

3:15pm - 3:35pm

Refreshment Break

3:35pm - 4:20pm

Keynote Presentation

Marisol Soengas

4:20pm - 6:00pm

PLENARY SESSION 7 - Understanding and Optimizing the Immunotherapy Response (II)

4:20pm - 4:40pm

Antibody-based immunotherapies for Melanoma

Rony Dahan

4:40pm - 4:55pm

Selected Abstract Talk

TBD

4:55pm - 5:15pm

What are the Limitations for Melanoma Cure?

Göran Jönsson

5:15pm - 5:30pm

Selected Abstract Talk

TBD

5:30pm - 5:45pm

Selected Abstract Talk

TBD

5:45pm - 6:05pm

Understanding the Effect of ICB by Mapping the Ecosystem of the Anti-Tumor Immune Response in Melanoma

Reinhard Dummer

7:00pm - 11:00pm

Awards Ceremony - Off Site